Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Respirology ; 28(11): 1036-1042, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37534632

RESUMEN

BACKGROUND AND OBJECTIVE: Racial disparities have been documented in care of many respiratory diseases but little is known about the impact of race on the treatment of interstitial lung diseases. The purpose of this study was to determine how race and ethnicity influence treatment of idiopathic pulmonary fibrosis. METHODS: Adults with idiopathic pulmonary fibrosis (>18 years) were identified using TriNetX database and paired-wised comparisons were performed for antifibrotic treatment among White, Black, Hispanic and Asian patients. Mortality of treated and untreated IPF patients was compared after propensity score matching for age, sex, nicotine dependence, oxygen dependence and predicted FVC. Additional comparisons were performed in subgroups of IPF patients older than 65 years of age and with lower lung function. RESULTS: Of 47,184 IPF patients identified, the majority were White (35,082), followed by Hispanic (6079), Black (5245) and Asian (1221). When subgroups were submitted to matched cohort pair-wise comparisons, anti-fibrotic usage was lower among Black patients compared to White (6.2% vs. 11.4%, p-value <0.0001), Hispanic (10.8% vs. 20.2%, p-value <0.0001) and Asian patients (9.6% vs. 14.7%, p-value = 0.0006). Similar treatment differences were noted in Black individuals older than 65 years and those with lower lung function. Mortality among White patients, but not Hispanic, Black, or Asian patients, was lower in patients on antifibrotic therapy versus not on therapy. CONCLUSION: This study demonstrated that Black IPF patients had lower antifibrotic use compared to White, Hispanic and Asian patients. Our findings suggest that urgent action is needed to understand the reason why racial disparities exist in the treatment of IPF.


Asunto(s)
Antifibróticos , Disparidades en Atención de Salud , Fibrosis Pulmonar Idiopática , Adulto , Humanos , Etnicidad/estadística & datos numéricos , Hispánicos o Latinos/estadística & datos numéricos , Fibrosis Pulmonar Idiopática/tratamiento farmacológico , Fibrosis Pulmonar Idiopática/epidemiología , Fibrosis Pulmonar Idiopática/etnología , Fibrosis Pulmonar Idiopática/mortalidad , Disparidades en Atención de Salud/etnología , Disparidades en Atención de Salud/estadística & datos numéricos , Antifibróticos/uso terapéutico , Negro o Afroamericano/estadística & datos numéricos , Blanco/estadística & datos numéricos , Asiático/estadística & datos numéricos , Estados Unidos/epidemiología
2.
BMC Cancer ; 22(1): 797, 2022 Jul 19.
Artículo en Inglés | MEDLINE | ID: mdl-35854273

RESUMEN

BACKGROUND: The inverse relationship between BMI and lung cancer diagnosis is well defined. However, few studies have examined the racial differences in these relationships. The purpose of this paper is to explore the relationships amongst race, BMI, and lung cancer diagnosis using the National Lung Screening Trial (NLST) data. METHODS: Multivariate regression analysis was used to analyze the BMI, race, and lung cancer diagnosis relationships. RESULTS: Among 53,452 participants in the NLST cohort, 3.9% were diagnosed with lung cancer, 43% were overweight, and 28% were obese. BMI was inversely related to lung cancer diagnosis among Whites: those overweight (aOR = .83, 95%CI = .75-.93), obese (aOR = .64, 95%CI = .56-.73) were less likely to develop lung cancer, compared to those with normal weight. These relationships were not found among African-Americans. CONCLUSION: Our findings indicate that the inverse relationship of BMI and lung cancer risk among Whites is consistent, whereas this relationship is not significant for African-Americans. In consideration of higher lung cancer incidence among African Americans, we need to explore other unknown mechanisms explaining this racial difference.


Asunto(s)
Neoplasias Pulmonares , Sobrepeso , Índice de Masa Corporal , Detección Precoz del Cáncer , Humanos , Pulmón , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/epidemiología , Obesidad/complicaciones , Obesidad/epidemiología , Factores Raciales
3.
Cureus ; 16(5): e60811, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38910681

RESUMEN

After encountering a unique patient case, we revisit the updated literature on stress ulcer prophylaxis with more updated studies. A 47-year-old male came to the hospital and was found to have acute cholecystitis. After undergoing urgent cholecystectomy, the patient developed melena and a 6 mg/dL drop from 12.5 g/dL to 6.5 g/dL in hemoglobin. He was found to have a gastric ulcer and was started on a proton pump inhibitor, which posed the question of whether or not stress ulcer prophylaxis was indicated. Therefore, the pathophysiology of stress ulcer prophylaxis is refreshed, discussing the various mechanisms through which stress ulcers form in a clinical context. Then, the main risk factors and indications for stress ulcer prophylaxis are defined based on current literature, further investigating whether or not stress ulcer prophylaxis has shown benefit and protection in various patient groups. Additionally, this review discusses the adverse effects of stress ulcer prophylaxis, including dysbiosis, community-acquired pneumonia, nutritional deficiencies, drug interactions, and fractures. Finally, inappropriate stress ulcer prophylaxis and contributing factors to overutilization are discussed, and alternative approaches to prevent stress ulcer formation are covered, including early enteral nutrition. Overall, there are mixed conclusions on the effectiveness of stress ulcer prophylaxis in noncritical patients. There are many adverse effects and unnecessary costs associated with inappropriate administration, and many studies have found that it should be reserved for specific clinical indications.

4.
BMJ Case Rep ; 16(8)2023 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-37640409

RESUMEN

Opportunistic fungal infections are a major cause of mortality in immunosuppressed patients, with mucormycosis and aspergillosis as two of the most commonly identified fungal organisms. Coinfection with mucormycosis and aspergillosis is rare, but cases have been reported in literature, most commonly presenting as disseminated invasive fungal infection with cerebrorhino-orbital involvement in an immunocompromised patient. Infections are most commonly caused by direct implantation of spores with localised angioinvasion. Haematogenous spread is rare, with most cases secondary to haematological malignancies or intravenous drug use. Coinfection with mucormycosis and aspergillosis portends a poor prognosis, with a high mortality rate. Thus, prompt recognition and intervention are crucial to prevent poor outcomes. In this unique case report, we describe a case of isolated cerebral mucormycosis and aspergillosis coinfection, not previously reported in literature.


Asunto(s)
Aspergilosis , Coinfección , Neoplasias Hematológicas , Infecciones Fúngicas Invasoras , Mucormicosis , Humanos , Adulto , Mucormicosis/complicaciones , Mucormicosis/diagnóstico , Mucormicosis/tratamiento farmacológico , Huésped Inmunocomprometido
5.
Reg Anesth Pain Med ; 48(9): 454-461, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-37085287

RESUMEN

INTRODUCTION: Erector spinae plane blocks have become popular for thoracic surgery. Despite a theoretically favorable safety profile, intercostal spread occurs and systemic toxicity is possible. Pharmacokinetic data are needed to guide safe dosing. METHODS: Fifteen patients undergoing thoracic surgery received continuous erector spinae plane blocks with ropivacaine 150 mg followed by subsequent boluses of 40 mg every 6 hours and infusion of 2 mg/hour. Arterial blood samples were obtained over 12 hours and analyzed using non-linear mixed effects modeling, which allowed for conducting simulations of clinically relevant dosing scenarios. The primary outcome was the Cmax of ropivacaine in erector spinae plane blocks. RESULTS: The mean age was 66 years, mean weight was 77.5 kg, and mean ideal body weight was 60 kg. The mean Cmax was 2.5 ±1.1 mg/L, which occurred at a median time of 10 (7-47) min after initial injection. Five patients developed potentially toxic ropivacaine levels but did not experience neurological symptoms. Another patient reported transient neurological toxicity symptoms. Our data suggested that using a maximum ropivacaine dose of 2.5 mg/kg based on ideal body weight would have prevented all toxicity events. Simulation predicted that reducing the initial dose to 75 mg with the same subsequent intermittent bolus dosing would decrease the risk of toxic levels to <1%. CONCLUSION: Local anesthetic systemic toxicity can occur with erector spinae plane blocks and administration of large, fixed doses of ropivacaine should be avoided, especially in patients with low ideal body weights. Weight-based ropivacaine dosing could reduce toxicity risk. TRIAL REGISTRATION NUMBER: NCT04807504; clinicaltrials.gov.


Asunto(s)
Bloqueo Nervioso , Humanos , Anciano , Ropivacaína , Bloqueo Nervioso/efectos adversos , Dolor Postoperatorio/diagnóstico , Anestésicos Locales/efectos adversos , Manejo del Dolor
7.
J Mech Behav Biomed Mater ; 5(1): 206-15, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22100095

RESUMEN

Articular cartilage functions as a load-bearing tissue by virtue of a functional coupling between its hydrated proteoglycan component and its zonally differentiated fibrillar network. How degeneration influences this relationship at the macro-, micro-, and ultrastructural levels is investigated in this study. Healthy bovine patellae (N=9) and patellae exhibiting varying degrees of degeneration (N=16) formed the basis of the study. Cartilage-on-bone blocks obtained from each patella were subjected to creep loading under a nominal stress of 4.5 MPa via a rectangular planar indenter which incorporated a narrow channel relief space to create a defined region where the cartilage would not be directly loaded. Following the attainment of creep equilibrium each sample was chemically fixed while under load so as to preserve the deformed state of the cartilage matrix. The structural response of the matrix was then analysed using differential interference contrast (DIC) optical microscopy and scanning electron microscopy (SEM). The morphology of the cartilage matrix extruded into the channel relief region was dramatically influenced by the severity of degeneration. The microscopic and ultrastructural characteristics of the extruded matrix showed that the load response of bulk cartilage is determined primarily by the microstructural integrity of the strain-limiting tangential layer and the nano-level interconnectivity of the fibrillar network. In conclusion, this study showed that three mechanically significant structural features of cartilage are important: (1) the strain limiting surface layer; (2) the micro-level boundaries in its zonally differentiated structure, and (3) the extent of fibrillar interconnectivity. Degeneration degrades or destroys the articular surface and 'destructures' the fibrillar network such that the latter functions less effectively as a proteoglycan entrapment system.


Asunto(s)
Cartílago/fisiología , Cartílago/ultraestructura , Ensayo de Materiales , Animales , Fenómenos Biomecánicos , Cartílago/patología , Cartílago/fisiopatología , Bovinos , Fuerza Compresiva , Rótula/fisiología , Rótula/fisiopatología , Presión , Soporte de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA